These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 779864)

  • 21. Can rheologic variables be of prognostic relevance in arteriosclerotic diseases?
    Resch KL; Ernst E; Matrai A; Buhl M; Schlosser P; Paulsen HF
    Angiology; 1991 Dec; 42(12):963-70. PubMed ID: 1763830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Correlation between various hemorheological factors in peripheral obstructive arterial diseases].
    Perego MA; Artale F; Sergio G; Cramarossa L; Di Palma A
    Minerva Cardioangiol; 1980 Sep; 28(9):599-610. PubMed ID: 7007920
    [No Abstract]   [Full Text] [Related]  

  • 23. Rheologic findings in patients with acute central retinal artery occlusion.
    Kieswetter H; Körber N; Jung F; Reim M
    Graefes Arch Clin Exp Ophthalmol; 1983; 220(2):92-5. PubMed ID: 6862190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil].
    Caimi G; Catania A; Frazzetta F; Capobianco D; Francavilla G; Romano A; Sarno A
    Ric Clin Lab; 1983; 13 Suppl 3():465-8. PubMed ID: 6324326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased blood viscosity and fibrinolytic inhibitor in type II hyperlipoproteinaemia.
    Lowe GD; McArdle BM; Stromberg P; Lorimer AR; Forbes CD; Prentice CR
    Lancet; 1982 Feb; 1(8270):472-5. PubMed ID: 6121140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Blood rheological changes and their clinical significance in chronic arterial obstructive disease].
    Sternitzky R; Seige K
    Z Gesamte Inn Med; 1983 Jan; 38(1):1-7. PubMed ID: 6342278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination hemodilution and defibrinogenating therapy in chronic arterial occlusive diseases].
    Ehrly AM; Saeger-Lorenz K
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():332-3. PubMed ID: 349931
    [No Abstract]   [Full Text] [Related]  

  • 28. Hemorheology in spontaneous animal endocrinopathies.
    Windberger U; Bartholovitsch A
    Clin Hemorheol Microcirc; 2004; 31(3):207-15. PubMed ID: 15322326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemorheological changes in obese adolescents after short-term diet.
    Fanari P; Somazzi R; Nasrawi F; Ticozzelli P; Grugni G; Agosti R; Longhini E
    Int J Obes Relat Metab Disord; 1993 Sep; 17(9):487-94. PubMed ID: 8220650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical complications of renal transplantation. I. Graft and infectious complications in recipient.
    Lee DB; Prompt CA; Upham AT; Kleeman CR
    Urology; 1977 Jun; 9(6 Suppl):7-31. PubMed ID: 329526
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
    Weidinger P; Bilek M; Tekusch A
    Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
    Rosendo A; Sala Planell E; Latorre J; Marinello J; Olba L; Rutllant ML
    Rev Clin Esp; 1982 Mar; 164(5):313-6. PubMed ID: 7100546
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hemorrheological changes in peripheral obliterative arterial diseases].
    Bartoli V; Albanese B; Morini R; Pasquini G; Manescalchi PG
    Ric Clin Lab; 1983; 13 Suppl 3():209-18. PubMed ID: 6672997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective study of peripheral occlusive arterial disease in diabetes. III. Initial lipid and lipoprotein findings.
    Zimmerman BR; Palumbo PJ; O'Fallon WM; Ellefson RD; Osmundson PJ; Kazmier FJ
    Mayo Clin Proc; 1981 Apr; 56(4):233-42. PubMed ID: 7218883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on haematocrit in peripheral arterial disease.
    Lowe GD; Saniabadi A; Turner A; Lieberman P; Pollock J; Drury J
    Klin Wochenschr; 1986 Oct; 64(19):969-74. PubMed ID: 3784449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypophosphataemic osteomalacia after cadaveric renal transplantation.
    Moorhead JF; Wills MR; Ahmed KY; Baillod RA; Varghese Z; Tatler GL
    Lancet; 1974 Apr; 1(7860):694-7. PubMed ID: 4132420
    [No Abstract]   [Full Text] [Related]  

  • 37. Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
    Ehrly AM
    Angiology; 1976 Mar; 27(3):188-96. PubMed ID: 1078314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation, viscosity and degradation of artificial thrombi after cadaveric-donor kidney transplantation.
    Dintenfass L; Stewart JH
    Thromb Diath Haemorrh; 1971 Aug; 26(1):29-37. PubMed ID: 4939437
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of lovastatin on hemorheology in type II hyperlipoproteinemia.
    Koppensteiner R; Minar E; Ehringer H
    Atherosclerosis; 1990 Jul; 83(1):53-8. PubMed ID: 2390136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Statistical study on the effect of erythrocyte aggregation on blood filterability].
    Sergio G; Artale F; Espureo M; Perego MA
    Ric Clin Lab; 1983; 13 Suppl 3():323-6. PubMed ID: 6673007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.